The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heart-lung transplant recipients

Am J Clin Pathol. 1989 Aug;92(2):177-85. doi: 10.1093/ajcp/92.2.177.

Abstract

This study presents the clinical and laboratory observations on posttransplant lymphoproliferative disorders (PTLDs) occurring in 5 of 53 heart-lung transplantation recipients. Cervical lymph nodes, tonsils, lungs, and gastrointestinal tract were the common sites of involvement by PTLDs. The histopathologic findings showed a spectrum of lymphoid and immunoblastic proliferation ranging from diffuse hyperplasia to malignant lymphoma, immunoblastic or large cell type. All cases were associated with a primary Epstein-Barr virus infection, and viral DNA was demonstrated within the lesional tissue in three cases. Immunohistochemical and immunoglobulin gene rearrangement studies revealed a B-cell proliferation that was monoclonal in three cases and polyclonal in two cases. Compared with PTLDs arising in other organ transplant recipients, this series is remarkable for a high incidence of PTLDs (9.4%), a short interval to tumor diagnosis (2.2 months, mean), involvement of the primary allograft in three cases (60%), and the frequent development of bronchiolitis obliterans. Possible reasons for this distinct clinicopathologic profile are discussed.

MeSH terms

  • Adolescent
  • Adult
  • B-Lymphocytes / immunology
  • B-Lymphocytes / pathology
  • Child, Preschool
  • Female
  • Graft Rejection
  • Heart Transplantation*
  • Heart-Lung Transplantation*
  • Herpesvirus 4, Human / isolation & purification
  • Humans
  • Lung Transplantation*
  • Lymphocyte Activation
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / pathology*
  • Male
  • Postoperative Complications / pathology*
  • Tumor Virus Infections / immunology
  • Tumor Virus Infections / pathology*